<DOC>
	<DOCNO>NCT02778191</DOCNO>
	<brief_summary>Concomitant chemoradiotherapy improve overall survival patient locally advanced head neck squamous cell carcinoma ( LA-HNSCC ) compare radiotherapy alone . Cisplatin 100 mg/m2 day 1 , 22 43 widely use result considerable acute late toxicity . Three cycle carboplatin plus 5-fluorouracil ( 5-FU ) accept alternative chemotherapy regimen compare prospectively . The aim study compare tolerability , efficacy , toxicity quality life patient LA-HNSCC treat concomitant cisplatin carboplatin plus 5-FU .</brief_summary>
	<brief_title>Comparison Concomitant Cisplatin Versus Carboplatin 5-fluorouracil With Radiotherapy Locally Advanced Head Neck Squamous Cell Carcinoma</brief_title>
	<detailed_description>This retrospective comparison patient LA-HNSCC treat chemoradiotherapy 2 tertiary care center Netherlands ( UMCG VUmc ) , one center routinely give carboplatin plus 5FU ( UMCG ) center ( VUmc ) use high dose cisplatin standard care .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Stage IIIIV LAHNSCC hypopharynx , oropharynx , larynx , oral cavity Primary treatment concomitant chemoradiotherapy consist threeweekly cisplatin carboplatin plus 5FU Age â‰¤ 70 year No previous treatment head neck cancer No distant metastases Previous treatment head neck cancer Distant metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Head neck squamous cell carcinoma</keyword>
	<keyword>cisplatin</keyword>
	<keyword>carboplatin</keyword>
	<keyword>5-fluorouracil</keyword>
</DOC>